Loose Lips Sink Ships
This article was originally published in RPM Report
Executive Summary
In the debate over prescribing data, just a causal conversation between a sales rep and a physician can inspire efforts to ban the practice. The following anecdotes underscore the importance--and the difficulty-in maintaining control over sales forces.
You may also be interested in...
Data Mining Case Struck Down by Supreme Court; IMS Prepares for Future Battles
When the Supreme Court threw out a Vermont law that prevented pharmaceutical companies from using physician prescribing data for marketing purposes, the unexpectedly broad opinion was cheered by Big Pharma and data miners alike. But IMS Health is already gearing up for the next data mining battle. And this time, the company says, the fight will be about protecting patient privacy.
Flying Blind: Learning to Live Without Physician Prescribing Data
Physicians aren't happy about the prescribing information companies use to help develop sales and marketing activities, and they're doing something about it. Policies adopted by medical professionals--and legislation moving at the state level--threaten to cut off marketers' access to information about who prescribes their products. Pharma companies better prepare to adapt to new ways of tracking sales.
Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks
All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?